Castle Biosciences (NASDAQ:CSTL) reported second-quarter 2026 revenue of $103.5 million, up 20% from the prior-year period, as growth in its TissueCypher test and other core offerings supported results. The company raised its full-year revenue outlook to $365 million to $375 million, from a previous
Cohu (NASDAQ:COHU) reported second-quarter 2026 revenue of $149 million, up 38% from a year earlier and above the midpoint of its guidance, as demand for high-performance computing equipment and a recovery in several core semiconductor markets supported results.
President and CEO Luis Müller said r
Coinbase Global (NASDAQ:COIN) executives said the company is pursuing growth through a broader product lineup, stablecoin partnerships, subscriptions and infrastructure initiatives, while maintaining its focus on trusted custody and expanding its Base blockchain ecosystem.
During the company’s seco
CareDx (NASDAQ:CDNA) reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics company expanded testing services, completed the sale of its lab products business and began integrating the recently acquired NavDx specialty oncology platform.
Total revenue rose to $132 million
Cerus (NASDAQ:CERS) reported second-quarter product revenue growth of 10% year over year and raised the low end of its 2026 product revenue outlook, citing demand for its INTERCEPT blood-safety products in North America and overseas.
Product revenue totaled $57.4 million for the quarter ended June
AXT (NASDAQ:AXTI) reported record second-quarter revenue and a return to profitability, driven by strong demand for indium phosphide substrates used in optical connectivity for AI data centers. Management said it is accelerating capacity expansion as customer demand continues to exceed supply.
Seco
Baldwin Insurance Group (NASDAQ:BWIN) reported second-quarter 2026 revenue of $493 million, adjusted EBITDA of $117 million and adjusted diluted earnings per share of $0.48, as the company said momentum from recent partnerships and its CAC integration helped offset several transitory headwinds.
Chi
Asure Software (NASDAQ:ASUR) reported second-quarter 2026 revenue growth of 23% year over year, citing broad-based performance across its business lines, increased cross-selling and progress in its payroll tax, human capital management and artificial intelligence initiatives.
Total revenue rose to
Alignment Healthcare (NASDAQ:ALHC) reported second-quarter growth in membership, revenue and adjusted EBITDA, while raising the low end of its full-year profitability outlook and increasing its membership expectations for 2026.
Chairman and CEO John Kao said health plan membership reached 294,100 a
Industrial manufacturer Standex (NYSE:SXI) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 2.8% year on year to $228.3 ...
Diagnostics company Guardant Health (NASDAQ:GH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 44.3% year on year to $3...
With contracts with companies like Meta Platforms and over 50 opportunities to explore in the natural gas arena, Enbridge can keep generating the revenue needed to hike its dividend payout for the foreseeable future.
Digital banking company Axos Financial (NYSE:AX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 20.9% year on year to $379....
The Ultimate Guide to Getting Your Car Off the Ground in Dubai: Exploring Lift ServicesDubai’s bustle metropolis postulate practicality, and for many, the
